in the intensive care unit, or even deaths. the uk s medicines and healthcare products regulatory agency approved it. drjune raine, the regulator s chief executive, called it a sharpened tool in our armoury to help protect us against this disease as the virus continues to evolve. our health reporter explains more about what we know. all the vaccines used so far were designed against the original coronavirus that hit two years ago. this vaccine is designed against the original virus and the newer omicron variant of the virus. moderna tested it in 437 people and found in those people that it had a better immune response. our bodies were better able to fight omicron than compared to their original booster. the mhra have now authorised this vaccine and it s likely it will now be available as a booster vaccine in the autumn for people over 50 and people with health conditions. we don t yet know exactly
and found in early results that those people at the bigger immune response, to the variants, the 0micron variants around right now, and that is why the uk has approved this vaccine. there are 30 million doses available but 26 made people need a booster are eligible for a booster from september so not everyone will get this vaccine. the people eligible are the ones at highest risk and people in health and social care and people over 50. for those who don t get this new twin target vaccine expert site the other vaccines are still really good at preventing against severe disease, so it is important to get whatever vaccine is available to you. it whatever vaccine is available to ou. , . ., ., ., you. it will be comforting to everyone you. it will be comforting to everyone i you. it will be comforting to everyone i would you. it will be comforting to everyone i would have i you. it will be comforting to l everyone i would have though you. it will be comforting to i everyone i would hav
by uk regulators to use a booster vaccine against omicron, the highly transmissable variant of the covid virus. tests of the vaccine have shown that it is eight times more effective against the variant. moderna is now working with health officials to make it available to the uk public aged 18 and above. joining us live now is our health reporter, how much of a game changer could this be? the uk regulator sharpened to against the coronavirus. all the vaccines used so far were designed against the original virus but this is designed against the original virus and the omicron variant. moderna tested it and 437 people and found it had a better only in response against
potentially we just need one dose per year? potentially we ust need one dose er ear? . , per year? the uk medicines regulatory per year? the uk medicines regulatory authority - per year? the uk medicines regulatory authority has - per year? the uk medicines| regulatory authority has said per year? the uk medicines - regulatory authority has said this is a sharp tool in the armoury against coronavirus. it is the first vaccine approved across the world that targets two versions of coronavirus, the original coronavirus, the original coronavirus and the omicron version that has swept through the world since the end of last year. moderna did a trial of 437 adults. and it found that this newjab had a better immune response, allowed our bodies to find the omicron version of the virus better than its original poster. and it found that it was very good at fighting eba four and ba five versions of omicron, those versions of omicron spreading through the uk right now. the plan is that this ver
original vaccines out there that were designed against the original coronavirus drain back in 2020. this vaccine is designed to protect against that original strain and the omicron variant that is now common across the world. moderna did testing in about 437 people, and they say from these preliminary tests that these people had a better immune response against the omicron virus that is out there right now. we have yet to see how that will play out in the real world, but the authorities have not approved for people over 18. the question is, who will get it? we don t know that yet but we are expecting a decision quite soon. we do know there are about 26 million people in the uk that are due a booster in the autumn, people over 50, that are due a booster in the autumn, people over50, people that are due a booster in the autumn, people over 50, people in care homes, health care staff, people with health conditions. there are about 30 million doses of this updated mode are not vaccine that